Forte Biosciences (FBRX) Prepaid Assets (2016 - 2026)
Forte Biosciences (FBRX) reported Prepaid Assets of $6.9 million for Q1 2026, up 1433.85% year-over-year from $449000.0 in Q1 2025, and up 1531.99% quarter-over-quarter from $422000.0 in Q4 2025.
Forte Biosciences (FBRX) Prepaid Assets (2016 - 2026) Analysis & Trends
Forte Biosciences (FBRX) has 11 years of Prepaid Assets data on file, last reported at $6.9 million in Q1 2026.
- Prepaid Assets for Q1 2026 came in at $6.9 million, up 1433.85% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.9 million (up 1433.85% YoY), and the FY2025 annual result was $422000.0, down 85.84% from the prior year.
- Prepaid Assets rose to $6.9 million in Q1 2026 per FBRX's latest filing, from $422000.0 in the prior quarter.
- Over five years, Prepaid Assets peaked at $6.9 million in Q1 2026 and troughed at $70000.0 in Q4 2022.
- A 5-year average of $942235.3 and a median of $403000.0 in 2025 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2024 and 2025: Prepaid Assets surged 1706.67% in 2024, then tumbled 85.84% in 2025.
- A 5-year view of Prepaid Assets shows it stood at $70000.0 in 2022, then jumped by 135.71% to $165000.0 in 2023, then surged by 1706.67% to $3.0 million in 2024, then plunged by 85.84% to $422000.0 in 2025, then surged by 1531.99% to $6.9 million in 2026.
- Business Quant data shows FBRX's Prepaid Assets at $6.9 million in Q1 2026, $422000.0 in Q4 2025, and $403000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Forte Biosciences | 70.77 Mn | 12.55 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.89 Mn |
| Dec 31, 2025 | 422,000.00 |
| Sep 30, 2025 | 403,000.00 |
| Jun 30, 2025 | 588,000.00 |
| Mar 31, 2025 | 449,000.00 |
| Dec 31, 2024 | 2.98 Mn |
| Sep 30, 2024 | 274,000.00 |
| Jun 30, 2024 | 1.21 Mn |
| Mar 31, 2024 | 280,000.00 |
| Dec 31, 2023 | 165,000.00 |
| Sep 30, 2023 | 917,000.00 |
| Jun 30, 2023 | 129,000.00 |
| Mar 31, 2023 | 109,000.00 |
| Dec 31, 2022 | 70,000.00 |
| Sep 30, 2022 | 546,000.00 |
| Jun 30, 2022 | 298,000.00 |
| Mar 31, 2022 | 287,000.00 |
| Dec 31, 2021 | 387,000.00 |
| Sep 30, 2021 | 891,000.00 |
| Jun 30, 2021 | 217,000.00 |